Download Karen Doucette - University of Alberta

1
CURRICULUM VITAE
Karen Elizabeth Doucette, MD, MSc, FRCPC
Place of Birth: Ottawa, Ontario Canada
Date of Birth: November 13, 1970
Office Address
University of
11350-83 Avenue
1-139 CSB
Edmonton, Alberta CANADA
T6G 2G6
Phone (780) 492-7686
Fax (780) 492-8050
Pager (780) 445-3277
e-mail: [email protected]
Home Address
9750 145 Street
Edmonton, Alberta CANADA
T5N 2W9
Cell (780) 920-6637
CURRENT POSITIONS
May 2015
Divisional Director, Division of Infectious Disease, Department of Medicine,
University of Alberta, Edmonton, Alberta, Canada
May 2015
Section Chief of Infectious Diseases
Alberta Health Services, Edmonton Zone
2010
Associate Professor, Department of Medicine, Division of Infectious
Diseases,
University of Alberta, Edmonton, Alberta, Canada
2008
Education Director, Transplant Infectious Diseases Fellowship,
University of Alberta, Edmonton, Alberta, Canada
LEAVES
Maternity leave: February – August 2011 (6 months)
EDUCATION
Degrees
2007
Masters of Science (Epidemiology),
Harvard School of Public Health, Boston, Massachusetts, USA
2003
Certificate, Summer Program in Clinical Effectiveness
Harvard School of Public Health, Boston, Massachusetts, USA
1996
Doctor of Medicine
Dalhousie University, Halifax, Nova Scotia, Canada
Revised: October 2015
2
1992
Bachelor of Science (Biology)
Dalhousie University, Halifax, Nova Scotia, Canada
Fellowships
2003-2004 Research and Clinical Fellow, Transplant Infectious Diseases
Massachusetts General Hospital, Boston, Massachusetts, USA
1999-2001
Infectious Diseases Fellowship
University of Manitoba, Winnipeg, Manitoba, Canada
1996-1999
Internal Medicine Residency
Queen’s University, Kingston, Ontario, Canada
Licences and Professional Qualifications
2012
Certification, Utilization of FibroScan® 502
2004
Registered Member, College of Physicians and Surgeons of Alberta
2001
Certificate, Infectious Diseases,
Royal College of Physicians and Surgeons of Canada
1999-2001
Registered Member,
College of Physicians and Surgeons of Manitoba
1999
Fellow, Internal Medicine,
Royal College of Physicians and Surgeons of Canada
1997
Licentiate
Medical Council of Canada
HONORS & AWARDS
2011
Cooperation, Collaboration and Teamwork Award (Hepatitis Support Program)
2010
Cooperation, Collaboration and Teamwork Award (Transplant ID)
2002
R. Samuel McLaughlin Research and Education Fellowship Award ($50 000)
University of Manitoba/Manitoba Medical Service Foundation
Awarded to residents who have completed residency training and are wishing
financial support to fund further medical fellowship training in research or medical
education deemed useful to the University. To support training in Transplant
Infectious Diseases
2002
Faculty Development Fund ($50 000)
Department of Medicine, University of Manitoba
To support training in Transplant Infectious Diseases
Revised: October 2015
3
1999
1999
Grand Prize, Best Resident Grand Rounds
“Antiretroviral Therapy for HIV Infection”
Queen’s University, Kingston, Ontario, Canada
Second Prize, Resident Research Day
“Outpatient Antibiotic Therapy for Endocarditis: A Cost Minimization Analysis”.
Queen’s University, Kingston, Ontario, Canada
1995
Department of Surgery Prize
Highest Mark in Surgery Examination
Dalhousie University, Halifax, Nova Scotia, Canada
1994
University Scholarship
High Academic Standing
Dalhousie University, Halifax, Nova Scotia, Canada
1994
Dr. J.V. Graham Award
High Standing in Anatomy - Med I & Med II
Dalhousie University, Halifax, Nova Scotia, Canada
1993
Professor D.L. Cameron Prize
Highest Standing in Anatomy - Med I
Dalhousie University, Halifax, Nova Scotia, Canada
1991
Joseph Duncan Scholarship
Academic Achievement
Dalhousie University, Halifax, Nova Scotia, Canada
PREVIOUS PROFESSIONAL/ACADEMIC POSITIONS HELD
11/2006-05/2015
Infectious Diseases Medical Director, Hepatitis Support Program,
Edmonton, Alberta, Canada
01/2004-06/2010
Assistant Professor, Department of Medicine, Division of Infectious
Diseases, University of Alberta, Edmonton, Alberta, Canada
02/2002-06/2002
Lecturer, Department of Internal Medicine, University of Manitoba,
Winnipeg, Manitoba, Canada
07/2001-12/2002
Associate Physician, Department of Medicine, Section of Hepatology,
Winnipeg Regional Health Authority
Infectious Diseases Consultant, Viral Hepatitis Investigative Unit, Winnipeg
Health Sciences Centre
PROFESSIONAL ASSOCIATION MEMBERSHIPS
Alberta Medical Association
Canadian Medical Association
Association of Medical Microbiology & Infectious Diseases of Canada
Revised: October 2015
4
American Association for the Study of Liver Diseases
Canadian Association for the Study of the Liver
Canadian Society of Transplantation
American Society of Transplantation (AST)
AST Infectious Diseases Community of Practice
Transplantation Society
AFC Committee in Solid Organ Transplantation
RESEARCH
Invited Presentations
11/14/2015 Infection in the Post-Transplant Patient
Rocky Mountain/ACP Internal Medicine Conference
Banff, Alberta
09/26/2015 The Success of Hepatitis C Therapies and the Challenges of HCV Elimination
Alberta Society of Infectious Diseases Annual Meeting
Banff, Alberta
04/18/2015 Addressing Unmet Medical Needs in HCV Genotype 3
Association of Medical Microbiology and Infectious Diseases Canada Annual
Meeting
Charlottetown, PEI
07/26/2014 Tuberculosis in Transplantation
World Transplant Congress Pre-Meeting Symposium Session
San Francisco, California, USA
27/09/2013 Targeted Liver Assessment
Alberta Hepatology Nurses Association Annual Meeting
Edmonton, AB
22/09/2013 EBV and PTLD in Transplantation
Canadian Transplant Fellows Symposium
Toronto, ON
2013/05/20 Tuberculosis in Transplantation
American Transplant Congress, Symposium Session
Seattle, Washington, USA
17/07/2012 Hepatitis B and HIV Co-Infection
Inner City Medicine Update
Winnipeg, MB
07/06/2012 Donor Derived Infectious Disease Transmission: Epidemiology and Risk Reduction
Combined Infectious Diseases and Nephrology Rounds
Halifax, NS
Revised: October 2015
5
07/06/2012 Update on Management of CMV in Organ Transplantation
Multi-organ Transplant Rounds
Halifax, NS
17/09/2011 EBV and PTLD in Transplantation
Canadian Transplant Fellows Symposium
Toronto, ON
15/09/2010 Hepatitis B Update
Hepatitis Support Program
Edmonton, AB
11/06/2010 Donor Derived Infectious Epidemiology and Risk Reduction
BC Transplant Day
Vancouver, BC
11/06/2010 CMV in Renal Transplant
BC Transplant Day
Vancouver, BC
09/06/2010 Infectious Disease screening of the organ donor: Balancing Risks of Transmission
with Wait List Mortality
Alberta Transplant Lecture Series
Edmonton, AB
08/05/2010 ABC of Transplantation Infectious Disease
Association of Medical Microbiology and Infectious Disease
Edmonton, AB
04/05/2010 CMV Ag vs PCR
American Transplant Congress
San Diego, CA
01/05/2010 Nontuberculous Mycobacteria in Solid Organ Transplant
American Transplant Congress
San Diego, CA
14/04/2010 HBV-Interpretation of Hepatitis B serological test results and treatment options of
those with acute and chronic hepatitis B infections
Corrections Canada
Edmonton, AB
26/03/2010 EBV/PTLD
Western Canada Multidisciplinary Pediatric Cardiac Rounds
Edmonton, AB
Revised: October 2015
6
17/10/2009 Epstein-Barr Virus and PTLD
Canadian Transplant Fellows Symposium
Toronto, ON
17/10/2009 Cytomegalovirus Prevention
Canadian Transplant Fellows Symposium
Toronto, ON
05/06/2009 Infection and PTLD
Pediatric Heart Transplant Boot Camp
Edmonton, AB
15/05/2009 CMV and EBV in SOT: What’s New in Prevention and Treatment
Manitoba Transplant Rounds
Winnipeg, MB
26/05/2009 Candidiasis Guideline Review
Infectious Diseases Residents Development Day
Edmonton, AB
08/04/2009 Hepatitis B in Canada
Canadian Liver Foundation: Living with Liver Disease Speaker Series
Edmonton, AB
28/01/2009 Update on HCV and HBV from AASLD
Edmonton, AB
25/02/2008 Update on CMV Prevention and Treatment
International Transplant Nurses Society
Toronto, ON
12/12/2007 Viral Infections in Non Renal Organ Transplant
Transplant Rounds
Saskatoon, SK
25/11/2007 HBV Therapy: Implications of Resistance
Canadian Liver Transplant Forum
Toronto, ON
13/10/2007 EBV and Posttransplant Lymphoproliferative Disorder
Canadian Transplant Fellows Symposium
Toronto, ON
05/05/2007 Approach to Fever in the Solid Organ Transplant Recipient
American Transplant Congress, Pre-meeting Symposium
San Francisco, CA
Revised: October 2015
7
15/03/2007 Hepatitis C in Lung Transplant: What Should We Be doing in Canada?
Canadian Lung Transplant Study Group Annual Meeting
Banff, AB
03/05/2006 Update on Hepatitis C Management
Grey Nuns Hospital Grand Medical Rounds
Edmonton, AB
22/04/2006 New Frontiers in Antifungal Therapy
Canadian Blood and Marrow Transplant Group Annual Meeting Sunrise Symposium
Edmonton, AB
31/03/2006 Cytomegalovirus in Organ Transplantation
Southern Alberta Transplant Rounds (ALTRA)
University of Calgary, Calgary, AB
23/03/2006 Tuberculosis in Solid Organ Transplant
Tuberculosis the Edge of Change: What’s New in an Old Disease (Annual Western
Canadian Conference on Tuberculosis Care)
Edmonton, AB
15/03/2006 Post Residency Training
Trainees Day
Association of Medical Microbiology and Infectious Diseases (Canada) Annual
Meeting
Victoria, B.C.
01/03/2006 Emerging Infections in Solid Organ Transplant
Canadian Association of Transplantation Annual Meeting
Mt. Tremblant, PQ
23/10/2004 Emerging Infections in Transplantation
Western Canada Infectious Disease Conference
Kananaskis, AB
25/02/2004 Emerging Infections in Transplantation
Department of Medicine Grand Rounds
University of Saskatchewan
Saskatoon, SK
25/02/2004 Infections in Solid Organ Transplantation
Internal Medicine Resident Rounds
University of Saskatchewan
Saskatoon, SK
9/11/2003
HBV/HCV Co-infection and HBV in Special Situations
Canadian Consensus Conference on the Management of Viral Hepatitis
Revised: October 2015
8
Ottawa, ON
06/03/2003 Treatment of HCV and HIV/HCV Co-infection
Canadian Infectious Disease Society Annual Meeting
Quebec City, PQ
07/06/2002 Hepatitis C and HIV Co-Infection
Canadian Hemophilia Society Annual Meeting
Saskatoon, SK
05/03/2002 What’s New in Hepatitis C Treatment Partners in Caring Conference
Health Canada and Correctional Services Canada
Winnipeg, MB
28/02/2002 Liver Transplantation in HIV/HCV Co-infected Individuals
Canadian Infectious Disease Society Annual Meeting
Banff, AB
Grants
2013
Pfizer Canada (15 000)
Principal Investigator
Incidence and Risk Factors for Enterococcal Infection Early Post-Liver Transplant
2010
Roche Canada ($14 000)
Principal Investigator
Molecular Diagnostic Testing of Patients with Chronic Hepatitis B Virus (HBV):
HBV Genotyping and HBsAg Titre Quantification
2006
University Hospital Foundation ($21 384)
Principal Investigator
Community Acquired Respiratory Virus infections following lung transplantation:
Molecular epidemiology and association with bronchiolitis obliterans
2006
Roche Canada Research Grant ($45 000)
Principal Investigator
Quantitative CMV and HHV-6 viral load in BAL samples of lung transplant
recipients and association with bronchiolitis obliterans
2006
Roche Canada Research Grant ($11 800)
Principal Investigator
An Assessment of Change from Antigenemia to CMV-PCR for Diagnosis and
Surveillance of CMV in a Multiorgan Transplant program
2005
Roche Canada Research Grant ($80 000)
Co-Investigator
CMV Infection in Solid Organ Transplant Recipients: Cellular Immune Response
and Viral Interactions
Revised: October 2015
9
2004
Astellas Research Grant ($20 000)
Principal Investigator
BK Polyomavirus and Renal Failure in Non-Renal Solid Organ Transplant
Recipients: A Case Control Study
2004
Astellas Research Grant ($65 000)
Co-investigator
Prospective monitoring for BKV nephropathy in recipients of kidney or combined
kidney-pancreas transplants
Reviewer
2008-current Ad-hoc reviewer for American Journal of Transplantation, Clinical Transplantation,
Transplant International, Clinical Infectious Diseases, Canadian Journal of
Gastroenterology, Transplant Infectious Diseases, Liver Transplantation
2014
Ad-hoc grant reviewer for
Roche Organ Transplantation Research Foundation
2009-14
Abstract Reviewer
American Transplant Congress Abstract Review Committee
2009
Reviewer for Canadian Society of Transplantation
Kidney Disease Improving Global Outcomes (KDIGO)
Clinical practice guideline for the care of kidney transplant recipients
Chapter 12 (Vaccination), 13 (Viral Diseases) and 14 (Other Infections)
2009
Reviewer for
2nd Edition- AST Transplant ID Guidelines
 BK Virus
 Resistant gram positive bacteria
2008
Manuscript reviewer for
The Canadian Journal of Gastroenterology (2)
Transplant International (2)
American Journal of Transplantation (6)
2007
Manuscript reviewer for
Frontiers in Bioscience [1]
Transplant International [1]
Canadian Journal of Gastroenterology [2]
American Journal of Transplantation [4]
Clinical Infectious Diseases [1]
2006
Manuscript reviewer for
American Journal of Transplantation [5]
Revised: October 2015
10
Clinical Infectious diseases [1]
2006
Grant reviewer for
The Physicians Services Incorporated Services (Ontario)
2005
Manuscript reviewer for
American Journal of Transplantation [4]
2005
Reviewer
The Immunocompromised Traveller
Committee to Advise on Tropical Medicine and Travel (CATMAT), Public Health
Agency of Canada
2005
Reviewer
B-Lactams, First edition Drugs and Drugs
University of Alberta
2004
Manuscript reviewer for
American Journal of Transplantation [4]
Expert Reviews in Anti-Infective Therapy [1]
PUBLICATIONS
Peer Reviewed Manuscripts
1. S. Belga and K. Doucette. Hepatitis C in Non-Hepatic Solid Organ Transplant Candidates
and Recipients: A New Horizon. World Journal of Gastroenterology. In Press 2015.
2. Pittman C, Plitt S, Birse T, Doucette K, Romanowski B, Cooper R, Houston S, Shafran S,
Singh AE. Prevalence and correlates of HIV and Hepatitis B Virus co-infection in
Northern Alberta, Canada. Can J Infect Dis and Med Microbiol January/February 2014,
Volume 25 Issue 1: e 8-e 13.
3. Stephen E Congly, Karen E Doucette, Carla S Coffin. Outcomes and management of viral
hepatitis and human immunodeficiency virus co-infection in liver transplantation. World
Journal of Gastroenterology 2014 January 14; 20(2): 414-424.
4. Meaghan O'Brien, Jim McHattie, Harris Paul, Emokpare Didi, Lawrence Worobetz, Karen
Doucette, Kelly Kaita, Steve Wong, Julia Uhanova, Chris Usaty, Gerald Y. Minuk.
Treatment of Chronic Hepatitis C in a Canadian Aboriginal Population: Results from the
PRAIRIE Study. Canadian Journal of Gastroenterology & Hepatology. December 2013,
27 (12) 707-710.
5. Stephen Congly, Philip Wong, Said Al-BUsafi, Karen Doucette, Scott Fung, Peter Gali,
Kevin Fonseca, Robert Myers, Carla Osiowy, Carla Coffin. Characterization of Hepatitis B
Virus Genotypes and Quantitative Hepatitis B Surface Antigen Titres in North American
Tertiary Referral Liver Centres. Liver International October 2013, 33 (9) 1363-1369.
Revised: October 2015
11
6. J Weinkauf, L Puttagunta, R Nador, K Jackson, K LaBranche, A Kapasi, J Mullen, D
Modry, K Stewart, S Meyer, M Thakrar, K Doucette, D Lien. Long-Term Outcome of Lung
Transplantation in Previous Intravenous Drug Users with Talc Lung Granulomatosis.
Transplantation Proceedings July-August 2013, 45 (6) 2375-2377.
7. Doucette K, Al-Saif M, Kneteman N, Chui L, Tyrrell GJ, Kumar D, Humar A. DonorDerived Bacteremia in liver Transplant Recipients Despite Antibiotic Prophylaxis.
American Journal of Transplantation April 2013, 13 (4) 1080-1083.
8. Joan Robinson, Karen Doucette. The natural history of hepatitis C virus infection
acquired during childhood. Liver International 2012, 32 (2) 258–270
9. P Tandon, K Doucette, K Fassbender, B Vandermeer, T Durec, DM Dryden. Granulocyte
colony-stimulating factor for hepatitis C therapy-associated neutropenia: systematic
review and economic evaluation. Journal of Viral Hepatitis 2011, 18, e381-e393
10. R Avery, H Clauss, L Danziger-Isakov, J Davis, K Doucette, D van Duin, J Fishman, F
Gunseren, A Humar, S Husain, C Isada, K Julian, D Kaul, D Kumar, S Martin, M Michaels,
M Morris, F Silveira, A Subramanian. Recommended curriculum for subspecialty training
in transplant infectious disease on behalf of the American Society of Transplantation
Infectious Diseases Community of practice Educational Initiatives Working Group.
Transpl Infect Dis 2010: 12: 190-194
11. Jia Hu, Karen Doucette, Lisa Hartling, Lisa Tjosvold, Joan Robinson. Treatment of
Hepatitis C in Children: A Systematic Review. PLoS ONE 5(7): e11542.
Doi:10.1371/journal.pone.0011542
12. Deepali Kumar, Shahid Husain, Maggie Hong Chen, George Moussa, David Himsworth,
Oriol Manuel, Sean Studer, Diana Pakstis, Kenneth McCurry, Karen Doucette, Joseph
Pilewski, Richard Janeczko, and Atul Humar. A Prospective Molecular Surveillance Study
Evaluating the Clinical Impact of Community-Acquired Respiratory Viruses in Lung
Transplant Recipients. Transplantation: Volume 89, Number 8, April 27, 2010.
13. J Levitsky, K Doucette, and the AST Infectious Diseases Community of Practices. Viral
Hepatitis in Solid Organ Transplant Recipients. American Journal of Transplantation
2009; 9 (Suppl 4): S116-S130.
14. Deepali Kumar, Shahid Husain, George Moussa, Karen Doucette, Oriol Manuel, Justin
Weinkauf, Joseph Pilewski, David, Himsworth, Richard Janeczko, Kenneth R. McCurry,
Sean M. Studer, Atul Humar. A Prospective Molecular Surveillance Study Evaluating the
Clinical Impact of Community Acquired Respiratory Viruses in Lung Transplant
Recipients. Transplantation April 2010; 89(8): 1028-33.
15. K. Doucette, V. Robson, S.D. Shafran, D. Kunimoto, Division of Infectious Diseases;
Hepatitis Support Program, University of Alberta, Edmonton, AB. Improving Access to
Care by Allowing Self Referral to a Hepatitis C Clinic. Can J. Gastroenterology June
2009;23(6): 421-424.
Revised: October 2015
12
16. Oriol Manuel, Xiaoli Pang, Atul Humar, Deepali Kumar, Karen Doucette, Jutta K.
Preiksaitis. An Assessment of Donor-to-Recipient Transmission Patterns of Human
Cytomegalovirus by Analysis Viral Genomic Variants. Journal of Infectious Diseases.
2009;199:1621-8.
17. Andrew L. Mason, Karen Doucette, Gane Ka-Shu Wong. Metagenomics and the Case of
the Deadly Hamster. Hepatology. 2008; 48(2): 679-83.
18. Gourishankar S, Doucette K, Fenton J, Purych D, Kowalewska-Grochowska K, Preiksaitis
J. The use of donor and recipient screening for toxoplasma in the era of universal
trimethoprim sulfamethoxazole phophylaxis. Transplantation. 2008; Apr 15; 85(7):9805.
19. Doucette KE, Pang XL, Jackson K, Burton I, Carbonneau M, Cockfield S, Preiksaitis JK.
Prospective monitoring of BK polyomavirus infection early post-transplantation in
nonrenal solid organ transplant recipients. Transplantation. 2008; 85(12):1733-6.
20. Doucette KE, Weinkauf J, Sumner S, Ens K, Lien D. Treatment of hepatitis C in potential
lung transplant candidates. Transplantation. 2007;83(12):1652-5.
21. John C. Mullen, Antigone Oreopoulos, Dale C. Lien, Michael J. Bentley, Dennis L. Modry,
Ken Stewart, Timothy L.Winton, Kathy Jackson, Karen Doucette, Jutta Preiksaitis, and
Phil F. Halloran. A Randomized, Controlled Trial of Daclizumab vs. Anti-thymocyte
Globulin Induction for Lung Transplantation. The Journal of Heart and Lung
Transplantation 2007; 26(5):504.
22. Oriol Manuel, Atul Humar, Jutta Preiksaitis, Karen Doucette, Sandy Shokoples, Anton Y.
Peleg, Isabel Cobos, Deepali Kumar Comparison of the Quantiferon®-TB Gold Assay
with Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients with
Chronic Liver Disease Awaiting Liver Transplantation. American Journal of
Transplantation 2007; 7(12):2797-801
23. Xiaoli Pang, Karen Doucette, Barbara LeBlanc, Sandra Cockfield, Jutta Preiksaitis.
Monitoring of polyoma BK viruria and viremia in renal allograft recipients using
quantitative real-time PCR assay: One year prospective study. Journal of Clinical
Microbiology 2007; 45(11):3568-73
24. Karen Doucette, Frank JMF Dor, Robert A Wilkinson, Stanley I Martin, Glenn Short,
Christene A Huang, Mason Freeman, David KC Cooper, David H Sachs, and Jay A
Fishman. Gene expression of porcine lymphotrophic herpesvirus-1(PLHV-1) in miniature
swine with posttransplant lymphoproliferative disorder. Transplantation 2007; 83:87-90
25. Duncan Webster, Rabia Ahmed, Puneeta Grover, Linda Chui, Ryan R McDonald, Arlene
Obarianyk, Nick Antonishyn, Karen Doucette. Staphylococcus aureus bacteremia in
patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus
infection. Journal of Viral Hepatitis 2007; 14:564-569
Revised: October 2015
13
26. Atul Humar, Karen Doucette, Deepali Kumar, Xiao-Li Pang, Dale Lien, Kathy Jackson,
and Jutta Preiksaitis. Assessment of adenovirus infection in adult lung transplant
recipients using molecular surveillance. The Journal of Heart and Lung Transplantation
2006; 25:1441-6.
27. Louise C Ivers, David Kendrick, and Karen Doucette. Reply to Lawn et al. Efficacy of
antiretroviral therapy programs in resource-poor settings: a meta-analysis of the
published literature. Clin Infect Dis 2005; 41:214-217.
28. Ivers, L, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in
resources poor settings: A meta-analysis of published literature. Clin Infect Dis 2005;
41:217-24.
29. Minuk GY, Sun D, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K,
Martin B, Giulivi A. Occult hepatitis B virus infection in a North American Communitybased population. J Hepatol 2005; 42:480-485.
30. Dor FJMF, Doucette KE, Mueller NJ, Wilkinson RA, Bajwa JA, McMorrow IM, Tseng Y-L,
Kuwaki K, Houser SL, Sachs DH, Fishman JA, Cooper DKC, Huang CA. Posttransplant
lymphoproliferative disease after allogeneic spleen transplantation in miniature swine.
Transplantation 2004; 78:286-291.
31. Doucette KE and Fishman JA. Nontuberculous mycobacterial infections in hematopoietic
stem cell and solid organ transplant recipients. Clin Infect Dis 2004; 38(10):1428-44.
32. K. Watt, J. Uhanova, Y. Gong, K. Kaita, K. Doucette, N. Pettigrew, G. Y. Minuk. Serum
Immunoglobulins Predict the Extent of Hepatic Fibrosis in Patients with Chronic Hepatitis
C Infections. J Viral Hepat 2004; 11:251-256.
33. Doucette KE, Bow EJ, Gallbraith P, Rendina A, Binda B, Embil M. Disseminated
zygomycosis: a rare cause of infection in patients with hematologic malignancies. J
Trauma 2003; 55:568-70.
34. Doucette KE and Aoki FY. Oseltamivir: A clinical and pharmacological perspective. Exp
Opin Pharmacother 2001; 2(10):1671-1683.
35. John M. Embil, Lorne Hurst and Karen Doucette. Photo quiz: Eczema herpeticum. Clin
Infect Dis 2001;32:1480, 1500-01.
Guidelines
1. S. Huprikar, L. Danziger-Isakov, J. Ahn, S. Naugler, E. Blumber, R.K. Avery, C. Koval, E.D.
Lease, A. Pillai, K.E. Doucette, J. Levitsky, M.I. Morris, K. Lu, J.K. McDermott, T. Mone, J.P.
Orlowski, D.M. Dadhania, K. Abbott, S. Horslen, B.L. Laskin, A. Mougdil, V.L. Venkat, K.
Korenblat, V. Kumar, P. Grossi, R.D. Bloom, K. Brown, C.N. Kotton and D. Kumar. Solid
Organ Transplantation From Hepatitis B Virus-Positive Donors: Consensus Guidelines for
Recipient Management. American Journal of Transplantation 2015; 1-11.
Revised: October 2015
14
2. Josh Levitsky and Karen Doucette. American Society of Transplantation Infectious Disease
Guidelines: Viral Hepatitis. American Journal of Transplantation 2013; 13: 147-168
3. Josh Levitsky and Karen Doucette. American Society of Transplantation Infectious Disease
Guidelines: Viral Hepatitis. American Journal of Transplantation 2009;9 (Suppl 4): S112 –
S126
4. Haddad H, Isaac D, Legare JF, Pflugfelder P, Hendry P, Chan M, Cantin B, Giannetti N,
Zieroth S, White M, Warnica W, Doucette K, Rao V, Dipchand A, Cantarovich M, Kostuk W,
Cecere R, Charbonneau E, Ross H, Poirier N. Canadian Cardiovascular Society Consensus
Conference update on cardiac transplantation 2008: Executive Summary. Canadian Journal
of Cardiology. 2009 April;25(4):197-205.
5. Morris Sherman, Stephen Shafran, Kelly Burak, Karen Doucette, Winnie Wong, Nigel
Girgrah, Eric Yoshida, Eberhard Renner, Philip Wong, Marc Deschenes. Management of
hepatitis B: Consensus Guidelines. Canadian Journal of Gastroenterology 2007;21(Suppl
C):25C-34C
6.
Morris Sherman, Stephen Shafran, Kelly Burak, Karen Doucette, Winnie Wong, Nigel
Girgrah, Eric Yoshida, Eberhard Renner, Philip Wong, Marc Deschenes. Management of
hepatitis C: Consensus Guidelines. Canadian Journal of Gastroenterology 2007; 21(Suppl
C):5C-24C
Technical Reports
1. Aruna Subramanian, Atul Humar, Robin Avery, Jay Fishman, Fenanda Silveira, Kathleen
Julian, Michelle Morris, Marian Michaels, Daniel Kaul, John Davis, Shahid Husain, Karen
Doucette, David van Duin, Stanely Martin, Heather Clauss, Filiz Gunseren, and Lara
Danziger-Isakov. Recommended Curriculum for Subspecialty Training in Transplant
Infectious Diseases On Behalf of the American Society of Transplantation Infectious
Diseases Community of Practice Educational Workgroup. Approved by AST Board June,
2009.
2. Donna M Dryden, Konrad Fassbender, Karen Doucette, Puneeta Tandon, Andrea Mine, Ben
Vandermeer, Tamara Durec. Granulocyte colony stimulating factor for the treatment of
antiviral-associated neutropenia in patients with hepatitis C. For the Canadian Agency for
Drugs and Technologies in Health. October 2008.
Non-Peer Reviewed Manuscripts
1. Barama A, Doucette K. Management of the transplant patient: Current perspectives.
Expert opinion: Review of Selected Abstracts: American Transplant congress 2005.
2. Doucette K. Oral infection and systemic disease: Q&A with Karen Doucette. Wellness
Options 2005; 22:29-29.
Revised: October 2015
15
3. Doucette KE, Kaita KDE. C What’s New: The World of Hepatitis C. Can J CME 2002;
14(2):153.
Published Abstracts
1. N. Zelyas, S. Smith, K. Doucette. Clostridium difficile infection in solid organ transplant
recipients at a tertiary care centre during 2006-2013. Can J Infect Dis Med Microbiology
2015; 26(2):e42.
2. Dima Kabbani, Glenda Meeberg, Carlos Cervera, Karen Doucette, Jutta Preiksaitis. Vascular
Jump Grafts in Liver Transplant: Does it Transmit Cytomegalovirus? Canadian Society of
Transplantation. Banff, AB, Canada, October 5-10, 2015.
3. Karen E Doucette, Marthe Charles, Mona Al Dabbagh and Jutta K Preiksaitis. Epidemiology
of Early Post Liver Transplant Infections 2008-12: Time to Reconsider Perioperative
Prophylaxis Regimen? American Transplant Congress. Philadelphia, PA, May 2-6, 2015.
4. Karen E Doucette, Kim Worton, Jim Kutsogiannis and Jutta K Preiksaitis. Utilization of
Increased Risk Donors in a Canadian Multi-Organ Transplant Program. American Transplant
Congress. Philadelphia, PA, May 2-6, 2015.
5. Catherine Burton, Karen Doucette, Curtis Mabilangan, Jutta Preiksaitis. Hepatitis B and C
Serologic Profiles of Organ Donors and Recipients Over a 10 Year Period at a Canadian
Transplant Center. Presented at World Transplant Congress in San Francisco, USA July 2631, 2014.
6. Karen Doucette and Sandeep Brar. Descriptive Analysis of HBV and HCV Positive Patients
Referred from a Refugee Clinic. Can J Infect Dis Med Microbiol 2014; 25 (2) Poster
Presentation AMMI Canada - CACMID Annual Conference in Victoria, BC April 3-5, 2014.
7. Stephanie Smith, Karen Doucette, Bryon Berenger. Epidemiology and risk factors for blood
stream infections in solid organ transplants over a ten-year period. ECCMID to be held in
Barcelona, Spain May 10-13, 2014.
8. Stephen Shafran, Karen Doucette, Julian Tang. A steady increase in proportion of HCV
infections due to genotype 3 in the Canadian province of Alberta from 1998 to 2013:
Implications for Therapy. International Liver Congress™ 2014 to be held in London, UK,
April 9-13, 2014.
9. Stephen E Congly, Maryam Rezaeeaval, Karen Doucette, Carla Osiowy, Samuel S Lee,
Robert P Myers, Carla S Coffin. Utility of Quantitative Hepatitis B Surface Antigen Titres in
the Classification of Chronic Hepatitis B (CHB) Disease Phases. Canadian Digestive Diseases
Week (CDDW) to be held in Toronto, Ontario February 7-11, 2014.
10. Anthea Peters, Marco Iafolla, Michael Akinwumi, Curtis Mabilangan, Lisa Elliott, Karen
Doucette, Jutta Preiksaitis. Epidemiology of Post-Transplant Lymphoproliferative Disorders
Following Solid Organ Transplant In a Major Canadian Transplant Centre. American Society
of Hematology AGM (poster). December 7-10, 2013; New Orleans, LA
Revised: October 2015
16
11. Anthea Peters, Carolyn J. Owen, Karen Doucette, Jutta Preiksaitis. Lymphopenia and EBERNegativity Predict Poor Survival in Post-Transplant Lymphoproliferative Disorder (PTLD)
Treated in the Rituximab Era. Am J Trans 2012; 352
12. Jutta Preiksaitis, Moacyr Silva, Mohammed Al-Kaabi, J. Yashu Coe, Sandra Cockfield, Karen
Doucette. Successful Treatment of Central Nervous System Posttransplant
Lymphoproliferative Disorder Using Rituximab and Reduction in Immunosuppression Alone.
Am J Trans 2012; 353
13. Jutta Preiksaitis, Curtis Mabilangan, Xiao-Li Pang, Bonita Lee, Karen Doucette. Risk of PostTransplant Lymphoproliferative Disorders (PTLD) in Children and Adults with Chronic
Epstein-Barr Virus Load Phenotype (CVLP). Am J Trans 2012; 353
14. Karen E. Doucette, Justin Weinkauf, Kathy Jackson, Dale Lien. Survival Following Lung
Transplantation Is Not Impacted by Hepatitis C Infection. Am J Trans 2012; 472-473
15. Shariq Haider, Michel Laverdiere, Colman Rotstein, Shaid Husain, Karen Doucette, Marvse
Power, Jeff Lipton, Peter Phillips, Eric Bow, Andre Galameau, Jean-Francois Pouliot. Liver
Safety of Posaconazole in Early Salvage Therapy for Invasive Fungal Infections Caused by
Molds and Yeasts. Infectious Diseases Society of America (IDSA). May 2012.
16. Anthea Peters, Karen Doucette. Lymphopenia and EBER-Negativity Predict Poor Survival in
Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab
Era. Poster session presented at: 53rd Annual Meeting of The American Society of
Hematology (ASH); December 10- 13, 2011; San Diego, CA.
17. Carmen Pittman, Sabrina Plitt, Edwin Birse, Karen Doucette, Barbara Romanowski, Ryan
Cooper, Stan Houston, Ameeta Singh. Prevalence, correlates, and outcomes of HIV and
Hepatitis B Virus co-infected patients in Northern Alberta. Poster session presented at:
Honouring our history, embracing our diversity. 20th Annual Canadian Conference on
HIV/AIDS Research (CAHR); 2011 Apr 15; Toronto, ON.
18. L Saxinger, S Fryters, K Doucette. Developing an Antifungal Prophylaxis Algorithm in High
Risk Neutropenic Patients Using Surveillance of Local Invasive Fungal Disease Prevalence
and Modeling Based on Published Data. Presented at the Association of Medical
Microbiology and Infectious Diseases Canada (AMMI Canada) annual meeting. Montreal PQ
– April 6-April 8, 2011.
19. Karen Doucette, Jeffery Venner, Jutta Preiksaitis. Comparison of CMV Antigenemia (Ag) and
PCR during Pre-Emptive Therapy Monitoring and Treatment of CMV Disease. American
Journal of Transplantation, Vol 10, Suppl 4, April 2010.
20. Karen Doucette, Bryan Dicken, David Bigam, Jutta Preiksaitis. Epstein-Barr Virus Viral Load
monitoring in High Risk, EBV Donor Seropositive (D+), Recipient Seronegative (R-(, Adult
and Pediatric Solid Organ Transplant (SOT) Patients Decreases Early Posttransplant
Lymphoproliferative Disorder (PTLD). American Journal of Transplantation, Vol 10, Suppl 4,
April 2010.
Revised: October 2015
17
21. Jia Hu, Karen Doucette, Lisa Hartling, Lisa Tjosvold, Joan Robinson. Treatment of Hepatitis
C in Children: A Systematic Review Submitted to Clinical Infectious Diseases. Can J Infect
Dis Med Microbiol, Vol 21, Suppl A, Spring 2010.
22. Curtis Cooper, Jean Robert, Victor S Feinman, Magdy Elkashab, Frank H Anderson, Linda J
Scully, Karen E Doucette, Helga B Witt-Sullivan, Robert J Bailey, Robert P Myers, John D
Farley, Barbara Romanowski, Robert Woolstencroft, Nabil Abadir, Cameron Ghent.
23. Outcomes of a Large, Inclusive Population Based Hepatitis C Treatment Program are Similar
to Randomized Controlled Trials: Interim Results of the Canadian Redipen Program.
Hepatology 2009;50(4):(703).
24. Deepali Kumar, Shahid Husain, George Moussa, Karen Doucette, Oriol Manuel, Justin
Weinkauf, Joseph Pilewski, David, Himsworth, Richard Janeczko, Kenneth R. McCurry, Sean
M. Studer, Atul Humar. A Prospective Molecular Surveillance Study Evaluating the Clinical
Impact of Community Acquired Respiratory Viruses in Lung Transplant Recipients.
American Journal of Transplantation 2008; May 8(2):231.
25. Karen Doucette, Deepali Kumar, Anthony Chow, Gregory Tyrell, Isabel Cobos, Atul Humar,
Dennis Kunimoto. Comparison of the Quantiferon-TB Gold to Tuberculin Skin Test for the
Diagnosis of Latent Tuberculosis Infection in Renal Transplant Candidates. American
Journal of Transplantation 2008; May 8(2):231.
26. Oriol Manuel, Xiaoli Pang, Atul Humar, Deepali Kumar, Karen Doucette, Jutta K. Preiksaitis.
An Assessment of Donor to Recipient Transmission Patterns of Human Cytomegalovirus by
Analyzing Viral Genomic Variants. American Journal of Transplantation 2008; May 8(2):232.
27. Deepali Kumar, Susan Chernenko, George Moussa, Jutta Preiksaitis, Karen Doucette, Oriol
Manuel, Isabel Cobos, Atul Humar. A Prospective Study of CD8+ T-Cell Mediated Immunity
to Cytomegalovirus (CMV) as a Predictor CMV Disease. American Journal of Transplantation
2008; May 8(2):266.
28. K. Doucette, V. Robson, D. Kunimoto, Division of Infectious Diseases; Hepatitis Support
Program, University of Alberta, Edmonton, AB. Improving Access to Care by Allowing Self
Referral to a Hepatitis C Clinic. Can J. Gastroenterology 2008; May 8(2):266.
29. Doucette, Karen: Weinkauf, Justin; Sumner, Suzanne; Ens, Karen; Lien, Dale. Treatment of
hepatitis C in potential lung transplant candidates. Transplantation 2007; 8:1:86:90.
30. Pang XL, Doucette K, LeBlanc B, Cockfield SM, Preiksaitis Jk. Monitoring of Polyomavirus
BK Virus Viruria and Viremia in Renal Allograft Recipients by Use of a quantitative Real-Time
PCR Assay: One-Year Prospective Study. J Clin Microbiology 2007; Nov 45(11):3568-73.
31. Karen Doucette, Kathleen Jackson, Helen Taskinen, Justin Weinkauf, Kenneth Stewart, John
Mullen, Dennis Modry, Dale Lien. Similar survival of hepatitis C positive and hepatitis C
Revised: October 2015
18
negative recipients following lung transplantation. American Journal of Transplantation
2007; 7 (Supp 2):502.
32. Oriol Manuel, Atul Humar, Jutta Preiksaitis, Karen Doucette, Sandy Shokoples, Anton Y.
Peleg, Isabel Cobos, Deepali Kumar Comparison of the Quantiferon®-TB Gold Assay with
Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients with Chronic
Liver Disease Awaiting Liver Transplantation. American Journal of Transplantation 2007; 7:
2797–2801.
33. Saxinger L, Parimi S, Doucette K, Fryters S, Gray M. Antifungal utilization and adherence
with guidelines in treating fungal infections in two tertiary care hospitals, 2002-2006. Can J
Inf Dis 2007; 18(1) (abstract D5):40.
34. Karen E. Doucette, Kathleen B. Jackson, Helen A. Taskinen, Justin G. Weinkauf, Kenneth C.
Stewart, John Mullen, Dennis L. Modry, Dale C. Lien. Similar Survival of Hepatitis C Positive
and Hepatitis C Negative Recipients Following Lung Transplantation. American Journal of
Transplantation 2007; 7 (supp 2):502.
35. Karen Doucette, Justin Weinkauf, Suzanne Sumner, Karen Ens, Dale Lien. Treatment of
Hepatitis C in patients awaiting lung transplantation. American Journal of Transplantation
August 2006; 6(suppl12):731. World Transplant Congress Poster Presentation, July, 2006.
36. Bryan J Dicken, David L Bigam, Jayne Fenton, Xiaoli L Pang, Jutta K Preiksaitis, Karen E
Doucette. Minimizing post transplant lymphoproliferative disease through Epstein Barr Virus
monitoring. American Journal of Transplantation 2006; 6(suppl 12):869-870.
37. XL Pang, K Doucette, B LeBlanc, SM Cockfield, and JK Preiksaitis. Monitoring BK virus in
renal allograft recipients using quantitative PCR. Poster Presentation European Society for
Clinical Virology. (Birmingham, U.K. September, 2006). Journal of Clinical Virology 2006;
36(supp 2):S44.
38. K Doucette, J Weinkauf, D Lien. Treatment of hepatitis C in lung transplant candidates.
Association of Medical Microbiology and Infectious Diseases Annual Meeting. Oral
Presentation. Canadian Journal of Infectious Diseases & Medical Microbiology 2006;
17(1:46).
39. Duncan Webster, Rabia Ahmed, Puneeta Grover, Linda Chui, Ryan R McDonald, Arlene
Obarianyk, Nick Antonishyn, Karen Doucette. Staphylococcus aureus bacteremia in patients
receiving pegylated interferon alfa and ribavirin for chronic hepatitis C infection. Oral
Presentation. Canadian Journal of Infectious Diseases & Medical Microbiology
2006;17(1:46).
40. Justin G Weinkauf, Dale C Lien, Ronald Damant, Neil M Skjodt, Karen Doucette, Kathleen B
Jackson, Pam J Brown, Helen A Taskinen, Ken C Stewart, John Mullen, Dennis L Modry.
Should lung transplantation be offered to previous intravenous drug users with Talc Lung
Granulomatosis? American Journal of Transplantation August, 2006; 6(supp12):730-731.
Revised: October 2015
19
41. Humar A, Doucette K, Kumar D, Pang X, Lien D, Jackson K, Fenton J, Siegel D, Preiksaitis J.
An assessment of adenovirus infection in adult lung transplant recipients using molecular
surveillance methods. American Transplant Congress, Seattle, WA, May 2005. American
Journal of Transplantation 2005;5:11:385.
42. Pang XL, Doucette K, Cockfield S, LeBlanc B, and Preiksaitis J. A novel real-time PCR assay
for the quantitation of polyoma BK virus in renal allograft recipients. Poster/Abstract
#TA35. Presented at Pan American Society for Clinical Virology Symposium May 8 – 11,
2005, Clearwater FL, USA.
43. Dor FJMF, Doucette KE, Mueller NJ, Wilkinson RA, Bajwa JA, McMorrow IM, Tseng Y-L,
Kuwaki K, Houser SL, Sachs DH, Fishman JA, Huang CA, Cooper DKC. Posttransplant
lymphoproliferative disease after allogeneic spleen transplantation in miniature swine.
American Transplant Congress, Boston MA, USA 2004. (Abstract 1110). American Journal
of Transplantation 2004; 4(Suppl 8):462.
44. Karen Doucette, Manna Zhang, Kim Hawkins, Kelly D Kaita, Gerald Y Minuk. Residual
hepatitis B infection. Hepatology 2002; 36(4, part 2 of 2):367A (abstract 822).
45. Doucette KE, Evans GA. Outpatient parenteral antibiotic therapy of endocarditis: A cost
minimization analysis (abstract). Can J Inf Dis 1999; 10 (supp D):91D.
Unpublished Abstracts
1. Shafiq Akbar and Karen Doucette. Herpes Simplex Virus (HSV) Reactivation Following
Renal and Liver Transplantation under Modern Immunosuppression. Canadian Society of
Transplantation March 2007.
2.
D Hobbs, A. Andonov, P Campbell, K. Doucette, B. Lee, G Taylor. Pseudo Healthcare
Transmission of HCV in A Renal Transplantation Patient. Community and Hospital
Infection Control Association - Canada (CHICA) Annual Meeting. June 2007
Book Chapters
1. Leah Remington and Karen Doucette. Prosthetic valve and device related endocarditis.
Chan KL, Embil JM, editors. Endocarditis: Diagnosis and Management (chapter 11).
Springer-Verlag London Limited, In Press 2015;
2.
Karen E Doucette and Jay A Fishman. Infections in the Immunocompromised Host.
Civetta, Taylor, and Kirby’s Critical Care, 5th Edition. Lippincott Williams & Wilkins. In
press 2015.
3.
Ryan Cooper and Karen Doucette. Tuberculosis: Epidemiology, Prevention, Diagnosis,
and Management (Chapter 131). Fishman’s Pulmonary Diseases and Disorders, 5th
Edition. McGraw-Hill. Editors, Drs. Michael A. Grippi, Jack A. Elias, Jay A. Fishman, Allan I.
Pack and Robert M. Senior. 2015: page 2012-31.
Revised: October 2015
20
4.
Karen E Doucette and Jay A Fishman. Infections in the Immunocompromised Host.
Civetta, Taylor, and Kirby’s Critical Care, 4th Edition. Lippincott Williams & Wilkins,
2008;(chapter 115):1717-31.
5.
Wendy Sligl, MD and Karen Doucette, MD. Prosthetic valve and device related
endocarditis. Chan KL, Embil JM, editors. Endocarditis: Diagnosis and Management.
Springer-Verlag London Limited, 2006; (chapter 4); 201-13.
TEACHING (see Teaching CV for details)
Gilbert Scholars – Teaching clinical skills to year 2 medical students (2011-2014)
Program Director Transplant Infectious Diseases, University of Alberta since January 2008
Clinical Teaching of medical students and residents on Infectious Diseases Consult Service
(2 weeks per year). University of Alberta 2004 – present.
Clinical Teaching of subspecialty residents and Transplant ID Fellow on Transplant
Infectious Diseases Consult Service (16-18 weeks per year). University of Alberta 2004 –
present.
Infectious Diseases Ambulatory Clinic teaching (Residents, Medical Students). University of
Alberta 2004 – present.
Undergraduate problem-based learning (Discovery Learning) facilitator. University of
Alberta 2004 – present.
Supervisor of student and resident research projects
2015 – Leah Remington R5 in Infectious Diseases
2014 – Marthe Charles R4 Internal medicine
2014 - Nathan Zelyas R4 in Medical Microbiology
2013 – Byron Berenger R3 in Medical Microbiology
2013 – Sandeep Brar R2 in Internal Medicine
2013 - Kevin Wen – R6 Renal Transplant Fellow
2012-2013 - Mona Al-Dabbagh – R6 in Transplant Infectious Diseases
2012-2013 – Catherine Burton - R6 in Transplant Infectious Diseases
2008-2009 - Leyla Asadi - R1 in Medicine
2006 - Jeffery Venner – BSc student
2006 - Sunil Parimi (co-supervisor) – Medicine year 1
2005-2006 – Shafiq Akbar – R2 in Medicine
2005-2006 – Bryan Dicken – R5 in Surgery
2004-2005 – Rabia Ahmed – R5 in Infectious Diseases
Lectures and Interactive case-based sessions for resident academic half-day (infectious
diseases, general internal medicine, nephrology, dermatology, critical care and pulmonary).
University of Alberta 2004 – present
Revised: October 2015
21
Continuing Medical Education – lectures and interactive sessions for faculty, community
physicians and allied health professionals: ~ 8-9 sessions/year
EDUCATIONAL MATERIALS DEVELOPMENT
Curriculum Development
2014
As member of the RCPSC Solid Organ Transplant Area of Focused
Competence Working Group significant contributions were made to the
development of the following documents: Competency Training
Requirements AFC Standards of Accreditation Competency Portfolio for the
Diploma in SOT Practice Eligibility Route Competency Portfolio
2013
Viral Hepatitis Rotation – University of Alberta Infectious Diseases
Subspecialty Training Program
Rotation for ID residents to increase their exposure patients with hepatitis
B and C to gain competence in management of these patients with an
ultimate goal to increase capacity to provide care for these patients in
Canada. The University of Alberta Infectious Diseases Division has a
unique ability in Canada to provide this focused training. The rotation has
now been made a mandatory 2 week rotation for ID SSR's and we have
offered it as an elective to ID trainees in Canada (with 3 requests in the 4
months since established).
The rotation includes:
 7-8 half day clinics per week, 1-2 sessions with the nurses, 2 casebased interactive one on one teaching sessions with a faculty
member, and 1 session focusing on virology (done by a virologist).
 A workbook to supplement education on topics that may be
inadequately covered in a 2 week clinic block (e.g. pregnancy, acute
HBV/HCV, management of cirrhosis). This is given to the resident at
the start of the rotation to work on during and then reviewed and
discussed with me at the end of the rotation.
2008 – 2009
Curriculum for Transplant Infectious Diseases Fellowship
Full curriculum (objectives, specific descriptions of rotations, outpatient
clinic schedule, educational and clinical rounds) developed. This is a
unique training program in Canada. Our first fellow entered the program in
September, 2008 and we have had 1 or 2 fellows each year since. Many of
our trainees have gone on to academic positions and success documented
by publications and awards. The curriculum document has served as one
of the models to develop a suggested curriculum for training Transplant ID
physicians through the American Society of Transplantation Infectious
Diseases Community of Practice.
2008 – 2009
Revised objectives/format of Infectious Diseases/Medical Microbiology
Journal Club and developed a template for article review and critical
appraisal for the presenting residents. Revisions to the format of the
journal club were made to re-focus the objectives on improving critical
Revised: October 2015
22
appraisal and a basic understanding of statistics and epidemiologic
methods.
2007 – 2008
Orientation Package: Transplant Infectious Diseases Rotation (for
Infectious Diseases Subspecialty Residents)
2007 – 2008
Transplant Infectious Diseases Overview (handout) for rotating
residents/students on Infectious Diseases consult service
OTHER PROFESSIONAL ACTIVITIES
Professional Development
2013-2014 Academic Leadership Development Program
This is a comprehensive learning program sponsored by the Office of the Provost
and VP (Academic) in partnership with the Faculty of Medicine & Dentistry, and
Organizational Learning and Effectiveness.
2013
Department of Medicine Mentorship Workshop
2013
The Transplantation Society Education Academy
World class leaders are engaged to provide a series of 12 webinars over the year
on key topics in medical education.
10/2013
Canada GCP (Good Clinical Practices)
Online course through NATRAC
10/2010
Teaching Enhancement Series
Context and Learning Part 2
Centre for Teaching and Learning
University of Alberta
Teaching Enhancement Series
Outcomes
Centre for Teaching and Learning
University of Alberta
Teaching Enhancement Series
Context and Learning Part 1
Centre for Teaching and Learning
University of Alberta
09/2010
Teaching Enhancement Series
Concept Mapping
Centre for Teaching and Learning
University of Alberta
09/2009
Investigator Training Program (ITP)
Revised: October 2015
23
03/2008
Problem Based Learning Module
For Discovery Learning
Division of Studies in Medical Education
University of Alberta
04/2007
Introductory Module
Problem Based Learning
Division of Studies in Medical Education
University of Alberta
03/2007
Promotions Workshop
Department of Medicine and Career Development Program
University of Alberta
05/2005
Building Research Capacity Workshop Series: Applying for Grants Workshop
Faculty of Medicine and Dentistry /HRS Staff Learning and Development/Research
Services Office
Formal Mentoring
2012-current - Dr. Stephanie Smith, Associate Professor
Clinical Protocol Development
The following protocols were developed to assist transplant physicians and coordinators in the
clinical management of transplant recipients and to act as a learning tool for trainees in all
areas of transplant medicine. Protocols can be found on the Capital Health Intranet website at:
www.intranet2.capitalhealth.ca/Transplant Services/infectious%20Disease.html
2015
Management of Respiratory Infections in Patients with Cystic Fibrosis Undergoing
Lung Transplantation - Alberta Transplant Protocols
2014
Increased Risk Donor Protocol Alberta Transplant Protocols
2014
Perioperative Prophylaxis in Liver Transplant Alberta Transplant Protocols
2014
Antimicrobial prophylaxis and dental procedures post transplantation
2013
Liver Transplantation in HIV-Infected Patients
2013
Antifungal Prophylaxis in Liver Transplantation
2013
Utilization of Hepatitis B surface antigen positive donors
2010
Hepatitis B in donors and recipients of non-hepatic solid organ transplant
2009
Antifungal Prophylaxis Post Lung Transplant
Revised: October 2015
24
2008
Antimalarial Prophylaxis and Immunosuppressive Drug Interactions
2008
Epstein Barr Virus and Posttransplant Lymphoproliferative Disease (revision)
2005
Interpretation and Management of Tuberculin Skin Test
2005
Epstein Barr Virus and Posttransplant Lymphoproliferative Disease
2005
Management of Donor and Recipient HBV Serology Results in Non-Hepatic Organ
Recipients
2005
Guidelines for Immunization of Immunocompromised Hosts (In conjunction with
Alberta Health and Wellness)
2004
Overview: Infection in Solid Organ Transplant Recipients
2004
General Medical Evaluation Pretransplant
2004
Recipient Pre-transplant Screening
2004
Donor Screening
2004
Interpretation and Response to Positive Donor Screening Results
2004
Prevention and Treatment of CMV in Solid Organ Transplantation (SOT)
EXAMINER
2008-2013 Appointed to:
Royal College of Physicians and Surgeons of Canada
Infectious Diseases Examination Board
2004-current Resident (R1-R4) In-Training Oral Examination
2007-2008
OSCE Examiner: Year 4 Medical Students
2005-2006
OSCE Examiner Year 4 Medical Students
2004-2005
OSCE Examiner: Year 3 Medical Students
2004-2005
OSCE Examiner: Year 4 Medical Students
2001
Medical Council of Canada Examiner
Qualifying Examination Part II
COMMITTEES
2015
Revised: October 2015
Department of Medicine Representative, Faculty Evaluation Committee
25
Faculty of Medicine & Dentistry, University of Alberta
2014-Present
Member, Canadian Society of Transplantation Education Committee
2012-Present
Member, Academic Appeals Committee
University of Alberta
2012-Present
Member, Canadian Society of Transplantation
RCPSC Certification Committee – This committee is charged with preparing
and submitting all training documents required for application to the
RCPSC, with a goal that Transplantation be approved as an Area of
Focused Competence (Diploma) in Canada. All training documents and
application under review by RCPSC at present.
2012-Present
Member, Alberta Transplant Institute Education Committee
2012-Present
Member, 3A Edmonton Clinic Management Committee
2008-Present
Member, American Society of Transplantation Infectious
Diseases Community of Practice Education Committee
2007-Present
Member, Infectious Diseases Residency Training Committee
University of Alberta
2006-Present
Member, Alberta Expert Review Panel for Blood Borne Infections in Health
Care Workers
Under Ministerial Order, Alberta Health and Wellness
2006-Present
Member, ID Clinical Trials Management
2005-Present
Member, HOPE Advisory Committee
Alberta Health Services
Edmonton, Alberta, Canada
2005-2011
Member, Regional Antimicrobial Stewardship Committee
Alberta Health Services
Edmonton, Alberta, Canada
2007-2010
Member, Medical and Scientific Advisory Committee to the Canadian
Hemophilia Society
2008-2009
Member, Medicine Clinics Patient Care Committee
Alberta Health Services and Department of Medicine, University of Alberta
June 2008
Department of Medicine Infectious Diseases Director Search & Selection
Committee
Revised: October 2015
26
2006-2008
Member at Large, Executive Committee, American Society of Transplantation
Infectious Diseases Community of Practice
1999-2001
Infection Control Committee
Health Sciences Center
Winnipeg, Manitoba, Canada
Revised: October 2015